Abstract
A series of 2-(2-(3-(4-chlorophenyl)-6-oxo-5,6-dihydropyridazin-1(4H)yl)acetyl)hydrazine carbothioamide and 2-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-6-(4-chlorophenyl)-4,5-dihydropyridazin-3(2H)-one derivatives were synthesized, characterized, and evaluated for anticonvulsant activity and muscle relaxant activity. The synthesized compounds 5d (82.75 %) and 5e (85.44 %) showed promising anticonvulsant activity by protection against tonic hind limb extensor phase in maximal electroshock model (MES) at (50 mg/kg) compared to standard drug phenytoin and also compounds 5d (82.75 %), and 5e (85.44 %) showed significant anticonvulsant activity by protection against pentylenetetrazole-induced generalized convulsions in pentylenetetrazole model (PTZ) at (100 mg/kg) compared to standard drug diazepam. On the other hand, compound 5e showed significant muscle relaxant activity (84.57 %) by rotarod and traction test model comparing with diazepam as a standard drug.
Similar content being viewed by others
References
Asif M (2010) Anticonvulsant and comparative structure activity relationship of pyridazine derivatives with currently clinically used anticonvulsants. J Adv Sci Res 1:35–45
Asif M, Singh A, Lakshmayya (2011) Anticonvulsant activity of 4-(substituted benzylidene)-6-(3-nitrophenyl)-4,5-dihydro pyridazin-3(2H)-ones against maximal electro shock induced seizure. Middle-East J Sci Res 9(4):481–485
Brodie MJ, Dichter MA (1996) Antiepileptic drugs. New Engl J Med 334:168–175
Dichter MA, Brodie MJ (1996) New antiepileptic drugs. New Engl J Med 334:1583–1590
Edith GK, Ales W, Winfried K, Marija (2002) Synthesis and structure investigations of potential sedative and anticonvulsant hydroxy- and acetoxy-N-(3-oxobutyl)-pyrido [2,3-d]pyridazinones. Monatshefte fur Chemie 133:1177–1185
Ghosh MN (1984) Fundamentals of experimental pharmacology. Hilton and Company, Kolkata, pp 187–190
Hallot A, Brodin R, Merlier J, Brochard J, Chambon JP, Biziere K (1986) Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino) pyridazines in animal models of epilepsy. J Med Chem 29:369–375
Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman AG (eds) (1996) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York, p 471
Jatav V, Mishra P, Kashaw S (2008) Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur J Med Chem 43:135–141
Javad KMM, Mahmood RM, Narjes O (2010) Anticonvulsant activity of Teucrium polium against seizure induced by PTZ and MES in mice. Iran J Pharm Res 9(4):395–401
Khan MSY, Siddiqui AA (2000) Synthesis and anti-inflammatory activity of some 6-aryl-2,3,4,5-tetrahydro-3-pyridazinones. Indian J Chem 39(B):614–619
Krall RJ, Penry JK, White BS, Kupferberg HJ, Swinyard EA (1978) Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19:409–428
Kulkarni SK (1999) Handbook of experimental pharmacology, 3rd edn. Vallabh Prakashan, New Delhi, pp 131–134
Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. Engl J Med 342(5):314–319
Kwan P, Brodie MJ (2004) Drug treatment of epilepsy: when does it fail and how to optimize its use. CNS Spectr 9:110–119
McIlwain KL, Merriweather MY, Yuva-Paylor LA, Paylor R (2001) The use of behavioral test batteries: effect of training history. Physiol Behav 73:705–717
Namdeo KP, Singh VK, Prajapati SK (2009) Synthesis of some 2-(substituted)-5-[(N-benzotriazolomethyl)-1,3,4-thiadiazolyl]-4-thiazolidinones for their anti-fungal activity. Indian J Pharm Edu Res 43(3):266–271
OECD (2001) Guidelines for testing of chemicals. Acute oral toxicity—up and down procedure, vol 425, pp 1–26
Oya U, Ayla B, Cenk A, Berna TM, Zafer G (2004) Synthesis and evaluation of the anticonvulsant activities of some 5-(4-substitutedbenzylidene)-6-methyl-4,5-dihydro pyridazine-3(2H)-ones. FABAD J Pharm Sci 29:185–194
Perio A, Chambon JP, Calassi R, Heaulme M, Biziere K (1986) Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats. J Pharmacol Exp Ther 239:542–547
Pooja SB, Sharma PK, Rajesh KN (2009) Synthesis and anticonvulsant activity of pyridazinone derivatives. Int J Chem Tech Res 1:522–525
Rubut C, Coudert P, Rfouvelet B, Tronche P, Bastide P, Bastide (1990) Anticonvulsant activity of 3-oxo-5-substituted bezylidene-6-methyl-(4H)-2-pyridazinylacetamides and 2-pyridazinylacetylhydrazides. J Chem Pharm Bull 38:3009–3013
Samanta KC, Asif M, Pooja Garg V, Sharma P, Singh R (2011) Synthesis of different substituted pyridazinone derivatives and their anticonvulsant activity E. J Chem 8(1):245–251
SamrJn EB, vanDuijn CM, Koch S, Hiidesmaa VK, Klepel H, Bardy AH, Mannagetta GB, Deichl AW, Gaily E, Granstron ML, Meinardi AH, Grobbee DE, Hofman A, Janz D, Lindhout D (1997) Maternal use of antiepileptic drugs and the risk of major congenital malfunction: a joint European prospective study of human teratogenesis associated with material epilepsy. Epilepsia 38:981
Sander JWAS, Shorvon SD (1996) Epidermiology of epilepsies. J Neurol Neurosurg Psychiatry 61:433–443
Schmidt D, Löscher W (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46(6):858–877
Shaharyar M, Akhter MW (2009) Synthesis and anticonvulsant activity of 2-(4-chlorophenyl) amino-5-(4-pyridyl)-1,3,4-oxadiazole. Acta Pol Pharm Drug Res 66(4):393–397
Siddiqui AA, Dogra A (2001) Synthesis and anti-inflammatory activity of some 2,6-diphenyl 2,3,4,5-tetrahydro-3-pyridazinones. Indian J Heterocycl Chem 10:215–218
Siddiqui AA, Kushnoor A, Wani SM (2004) Synthesis and anti-inflammatory activity of 6-(substituted aryl)-2,3,4,5-tetrahydro-3-thiopyridazinones. Indian J Heterocycl Chem 13:257–260
Siddiqui AA, Abdullah MM, Arora M, Islam M, Ahmad SR (2006) Synthesis of novel pyridazinones possessing anticonvulsant activity. Indian Drugs 43:790–794
Sivakumar RN, Anbalagan V, Gunasekaran JT, Leonard (2003) Synthesis and anticonvulsant activity of novel 1-substituted-1,2- dihydro-pyridazine-3,6-diones. Biol Pharm Bull 26:1407–1411
Smith MC, Bleck TP (1991) Convulsive disorder: toxicity of anticonvulsants. Clin Neuropharmacol 14:97–115
Tandon VR, Gupta RK (2005) An experimental evaluation of anticonvulsant activity of Vitex negundo. Indian J Physiol Pharmacol 49A(2):199–205
Upmanyu N, Gupta SP, Grover J, Mishra P (2009) Synthesis of valproic acid derivatives and their evaluation for anticonvulsant activity. Internet J Altern Med 7(1):1
Villar R, Laguna MR, Calleja JM, Cadavid I (1992) Effect of Skeletonema statum extracts on the central nervous system. Planta Med 38:398–403
Xu P, Wang SY, Chen Y, Liu WQ, Tao C (1991a) Studies on synthesis, anticonvulsant activity and the structure-activity relationships of 6-(substituted phenyl)-3(2H)pyridazinones. Yao Xue Xue Bao 26:656–660
Xu P, Wang SY, Liu WQ (1991b) Studies on synthesis and anticonvulsant activity of 3-GABAderivatives of 6-(substituted-phenyl) pyridazines. Yao Xue Xue Bao 26(9):650–655
Acknowledgments
The authors are thankful to the Director, SAIF, Punjab University, Chandigarh for IR, 1H NMR, 13C NMR, and Mass spectroscopy, Authors are also thankful to the Director and Head of the department, Institute of pharmacy, Bundelkhand University, Jhansi for providing facilities to conduct the research work and Mrs. Shalini pathak, department of pharmacology, for her support during the pharmacological screening.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sharma, B., Verma, A., Sharma, U.K. et al. Efficient synthesis, anticonvulsant and muscle relaxant activities of new 2-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives. Med Chem Res 23, 146–157 (2014). https://doi.org/10.1007/s00044-013-0618-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0618-0